Rafferty Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-218,237
| Closed | -$3.43M | – | 1204 |
|
|
2024
Q1 | $3.43M | Buy |
218,237
+78,655
| +56% | +$1.21M | 0.01% | 545 |
|
|
2023
Q4 | $2.25M | Sell |
139,582
-158
| -0.1% | -$2.02K | 0.01% | 641 |
|
|
2023
Q3 | $1.78M | Sell |
139,740
-91,351
| -40% | -$1.26M | 0.01% | 645 |
|
|
2023
Q2 | $3.25M | Sell |
231,091
-2,921
| -1% | -$41.8K | 0.02% | 505 |
|
|
2023
Q1 | $3.62M | Sell |
234,012
-18,611
| -7% | -$311K | 0.02% | 464 |
|
|
2022
Q4 | $4.14M | Buy |
252,623
+50,570
| +25% | +$822K | 0.03% | 417 |
|
|
2022
Q3 | $3.74M | Buy |
202,053
+45,467
| +29% | +$714K | 0.04% | 382 |
|
|
2022
Q2 | $2.06M | Sell |
156,586
-265,801
| -63% | -$2.93M | 0.02% | 455 |
|
|
2022
Q1 | $3.92M | Sell |
422,387
-125,610
| -23% | -$1.07M | 0.02% | 434 |
|
|
2021
Q4 | $5.35M | Buy |
547,997
+482,080
| +731% | +$9.07M | 0.03% | 368 |
|
|
2021
Q3 | $2.24M | Sell |
65,917
-7,731
| -10% | -$247K | 0.02% | 606 |
|
|
2021
Q2 | $2.7M | Sell |
73,648
-3,615
| -5% | -$140K | 0.02% | 546 |
|
|
2021
Q1 | $3.46M | Buy |
77,263
+60,902
| +372% | +$2.84M | 0.02% | 394 |
|
|
2020
Q4 | $934K | Sell |
16,361
-26,269
| -62% | -$1.56M | 0.01% | 522 |
|
|
2020
Q3 | $2.19M | Buy |
42,630
+25,012
| +142% | +$1.23M | 0.03% | 390 |
|
|
2020
Q2 | $1.05M | Buy |
+17,618
| New | +$942K | 0.01% | 533 |
|
|
2020
Q1 | – | Sell |
-33,415
| Closed | -$2.08M | – | 837 |
|
|
2019
Q4 | $2.08M | Sell |
33,415
-6,433
| -16% | -$306K | 0.03% | 373 |
|
|
2019
Q3 | $1.35M | Buy |
39,848
+9,293
| +30% | +$275K | 0.02% | 477 |
|
|
2019
Q2 | $689K | Sell |
30,555
-2,477
| -7% | -$58K | 0.01% | 630 |
|
|
2019
Q1 | $767K | Buy |
+33,032
| New | +$865K | 0.01% | 596 |
|
Other funds holding DCPH
Rafferty Asset Management's DCPH Position: Q2 2024 in Review
Rafferty Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 218,237 shares — an estimated $3.43M sold.
Rafferty Asset Management first reported a position in DCPH in Q1 2019 and held it in 20 quarters. The position peaked at $5.35M in Q4 2021. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Rafferty Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Rafferty Asset Management sold 218,237 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $3.43M.
- Rafferty Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
- Rafferty Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.35M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.